Donglai Chen

14PUBLICATIONS
10CO-AUTHORS
Molecular targetsPredictive and prognostic markersTumour immunologyLiquid biopsiesSocial epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Apr 01, 2026
STAT3-mediated transactivation of NOVA2 promotes lung adenocarcinoma metastasis by splicing SMAD4.

Shengjie Wang, Xin Tong, Runfeng Sun

|Aug 20, 2024
Does neoadjuvant therapy contribute to increased risk in anastomotic leakage of esophageal cancer? A network meta-analysis.

Da Zhou, Donglai Chen, Peidong Song

|Aug 03, 2024
Prognostic implications, genomic and immune characteristics of lung adenocarcinoma with lepidic growth pattern.

Yue Li, Donglai Chen, Yi Xu

|Apr 23, 2024
P4HA2 activates mTOR via hydroxylation and targeting P4HA2-mTOR inhibits lung adenocarcinoma cell growth.

Ersuo Jin, Shengjie Wang, Donglai Chen

|Mar 07, 2023
Clinical implications and molecular features of tertiary lymphoid structures in stage I lung adenocarcinoma.

Xuejun Xu, Yifeng Gao, Shanzhou Duan

|Sep 02, 2022
Log odds of positive lymph nodes is a robust predictor of survival and benefits from postoperative radiotherapy in stage IIIA-N2 resected non-small cell lung cancer.

Xing Jin, Donglai Chen, Yumei Shen

Pageof 3

Frequent Collaborators

10 joint publications

Yongbing Chen

3 joint publications

Junmiao Wen

2 joint publications

Shengjie Wang

2 joint publications

Runfeng Sun